Brain Tumor Chemotherapy With Methotrexate Given Intrathecally

Abstract
A new technique has been described for the intrathecal administration of cytotoxic agents with use of the components of a ventriculoatrial shunt. The results obtained in six patients given methotrexate intrathecally for a variety of intracranial tumors justifies further clinical trial.

This publication has 0 references indexed in Scilit: